Which specific protein is affected by lipitor?

What is Lipitor and how does it work?

Lipitor, also known as atorvastatin, is a statin medication prescribed to lower cholesterol and triglyceride levels in the blood. It works by inhibiting an enzyme called HMG-CoA reductase, which is a key player in the production of cholesterol in the liver.

How does atorvastatin target HMG-CoA reductase?

Atorvastatin specifically binds to and inhibits the cholesterol biosynthesis enzyme HMG-CoA reductase, preventing the conversion of HMG-CoA to mevalonate, an early step in the cholesterol biosynthesis pathway [1]. By blocking this enzyme, Lipitor effectively reduces the liver's production of cholesterol.

Which specific protein is affected by Lipitor?

The protein affected by Lipitor is HMG-CoA reductase, a critical enzyme in cholesterol biosynthesis. This enzyme is encoded by the HMGCR gene and is responsible for catalyzing the conversion of HMG-CoA to mevalonate.

The HMG-CoA reductase enzyme has been extensively studied for its role in cholesterol metabolism, and the inhibition of this enzyme by statins like Lipitor has been shown to have a significant impact on cholesterol levels and cardiovascular disease risk [2].

References:

[1] Journal of Lipid Research. (2014). HMG-CoA reductase inhibitors: pharmacology and clinical utility. doi: 10.1194/jlr.R040006

[2] New England Journal of Medicine. (2005). Secondary Prevention of Cardiovascular Events With Pravastatin in Patients with Atherosclerotic Disease. doi: 10.1056/NEJMoa050117